29
Diagnosis Dementia: Diagnosis, Assessment, and Referral Soo Borson MD University of Washington Department of Psychiatry and Behavioral Sciences, School of Medicine Department of Psychosocial and Community Health, School of Nursing

Diagnosis Dementia: Diagnosis, Assessment, and Referral Soo Borson MD University of Washington Department of Psychiatry and Behavioral Sciences, School

Embed Size (px)

Citation preview

Diagnosis Dementia:Diagnosis, Assessment, and

Referral

Soo Borson MDUniversity of Washington

Department of Psychiatry and Behavioral Sciences, School of Medicine

Department of Psychosocial and Community Health, School of Nursing

Hebert et al. Neurology 2004

New Cases of Alzheimer’s Disease

National Priorities for Dementia Care

• Detect cognitive impairment • Diagnose dementia when it’s present

– Dementia is… • A medical problem caused by specific disease processes,

and a target for medical treatment• A risk factor for other problems, and a modifier of other

conditions and treatments• A (usually) progressive condition with changing, stage-

specific problems and needs

• Provide dementia-specific, relevant, proactive , and comprehensive patient care

The Broad Impact of Dementia

• Health care– Delirium (OR 3.96, 95% CI 1.1-14.2) 1 – Low health literacy/adherence to pre-op instructions (OR

4.0, 95% CI 1.6-9.8) 2

– Med management deficits3

– More hospitalizations for ambulatory care sensitive conditions (OR 1.8, p < 0.0001)4

• Public safety– Driving risk 5

• At home, in the community– Need for everyday support and assistance 6

1. Alagiakrishnan et al. JAGS 2007. 2. Chew et al. Am J Surg 2004. 3. Lakey et al. Ann Pharmacother 2009. 4. Phelan et al (in prep). 5. AMA Driver Guide, http://www.ama-assn.org/ama/pub 6. Scanlan et al. Am J Geriatr Psychiatry 2007

© 3-11 Soo Borson MD

New Opportunities for Detecting Dementia in Primary Care

• The Medicare Annual Wellness Visit– New benefit - January 2011– Voluntary for patients and providers– No patient co-pay; Level 4 E/M for provider– Two assessment components

• Cognitive checkup – objective assessment• Health risk assessment

• One key goal: personal prevention plan• Missed opportunity

– Only 3-4% of seniors used the benefit in 1st half of 2012

Cognitive Assessment in the Annual Wellness Visit

• Many approaches– Ask the patient about problems with memory

or needing help to do things that used to be easy (e.g. paying bills)

– Ask someone else who knows the patient well– Give a screening test

• Some health care systems have adopted routine, systematic screening– Simple, uniform, quality control possible

1) GET THE PATIENT’S ATTENTION, THEN SAY: “I am going to say three words that I want you to remember. The words are:

Banana Sunrise Chair

Please say them for me now.” (Give the patient 3 tries to repeat the words. If unable after 3 tries, go to next item.)(Fold this page back at the TWO dotted lines BELOW to make a blank space and cover the memory words. Hand the patient a pencil/pen).

2)SAY ALL THE FOLLOWING PHRASES IN THE ORDER INDICATED: “Please draw a clock (provide paper, pencil). Start by drawing a large circle.” (When this is done, say) “Put all the numbers in the circle.” (When done, say) “Now set the hands to show 11:10 (10 past 11).”

SAY: “What were the three words I asked you to remember?”

___________________ ___________________ ____________________ (Score 1 point for each) 3-Item Recall Score

Score the clock (see other side for instructions): Normal clock 2 points Clock Score Abnormal clock 0 points

TOTAL SCORE = 3-ITEM RECALL PLUS CLOCK SCORE

Total score of 0, 1, or 2 possible impairment; 3, 4, or 5 suggests no impairment.

Case Study: Mini –Cog™

Mini-Cog™. Copyright Soo Borson MD All rights reserved.

Mini-Cog™

A NORMAL CLOCK HAS ALL OF THE FOLLOWING ELEMENTS:All numbers 1-12, each only once, are present in the correct order and direction (clockwise) inside the circle.Two hands are present, one pointing to 11 and one pointing to 2. ANY CLOCK MISSING ANY OF THESE ELEMENTS IS SCORED ABNORMAL. REFUSAL TO DRAW A CLOCK IS SCORED ABNORMAL.

Abnormal Hands Abnormal Spacing Abnormal Spacing/Numbers

Mini-CogTM . Copyright Soo Borson MD. All rights reserved.

Detecting Dementia with the Mini-Cog™

94(41%)194 (84%)231Total

4 (6) **39 (55)71 (32)Mild Cognitive Impairment

5 (45) *9 (82)11 (6) Other dementia types

6 (40) **15 (100)15 (6) Vascular dementia

15 (56) *20 (91)22 (10) AD + vascular

69 (62) **111 (99)112 (47)Dementias

Probable AD

byPhysicians

byMini-Cog

Total N(%‡)

Diagnosis

Recognition Rate, N (%)

Borson et al. Int J Geriatric Psychiatry 2006* p < 0.05; ** p < 0.01

Moving from Screening to Diagnosis

• Screening for cognitive impairment – Identifies the majority of patients with

dementia– Cannot diagnose dementia or its cause

• Diagnostic assessment appropriate after– Positive screen– Negative screen but high clinical suspicion

Components of the Diagnostic Workup

• Thorough medical and family history• Mental status testing• Physical and neurological examination• Laboratory examination

History

FIRST SYMPTOMS/SIGNS

• Forgetfulness• Executive

impairment• Psychiatric or

behavioral• Neuromotor

COURSE

•Insidious vs sudden onset•Smooth vs stuttering•Short term stability vs daily fluctuation

OTHER

•Disease-specific features•Comorbid conditions•Medications•Alcohol and other substance use•Family history +

Mental Status Testing• To establish presence of cognitive disorder

– Comparison with• Patient’s prior cognitive level • Normative expectations for the person

– Two or more core cognitive abilities affected• Memory and learning• Executive abilities• Language, cognitive control of motor acts, recognition of

objects, people• Visuospatial functions, navigation

– Everyday life affected by deficits

• To look for non-dementia causes, e.g. depression

Clinical Differential Diagnosis

Dementia present

Neuro exam normal

AD FTD

Neuro exam abnormal

VaD

PDD, ‘Park+’

DLB

Diagnostic Testing

• Routine “rule out” labs• Psychometric testing• Structural and functional neuroimaging

Pure AD

AD with severe cerebral amyloid angiopathy

Mild AD with vascular involvement

AD with vascular lesions

AD with CVD

VaD with AD changes

VaD with small-vessel disease

Pure VaD

Agüero-Torres H, Winblad B. Ann NY Acad Sci. 2000;903:547-552.

Common Patterns of Ischemic Vascular Dementia

Courtesy of T. Erkinjuntti.

Cortico-subcorticaloccipito-temporal infarct

Thalamic infarct

Cortical Strategic

Lacunar infarcts predominateWhite matter lesions predominate

Subcortical White Matter Subcortical Lacunar

DIAGNOSIS MRI SPECT/PET

Alzheimer Disease Med temporal, parietal atrophy; later, diffuse atrophy and ventricular enlargement

Parietotemporal assoc cortex, posterior cingulate; sensorimotor preservation

Frontotemporal Dementia

Frontal and/or lateral temporal atrophy

Prefrontal and temporal

Dementia with Lewy Bodies

Hippocampus, medial temporal preserved; putamen

atrophy

Parietotemporal plus occipital

Vascular Dementia Bilateral micro and/or macrovascular disease, no

set pattern

Asymmetric cortical, subcortical, cerebellar;

watershed; crossed cerebellar diaschisis;

lateralized hemispheric deficit

Pure AD

CONVENTIONAL SPECT IMAGES

3D – SSP PROCESSED IMAGES

Pure AD

FUSED MRI/SPECT IMAGES

AD + Vascular Disease

Lewy Body Dementia

Contribution of Combined MRI/SPECT to Diagnosis

• Findings significant for diagnosis in 78.5%• Pre-imaging diagnosis of neurodegenerative disease

rejected by imaging in 2.5%• Vascular component identified in 41 patients (51% of

sample)– 30% exclusively vascular – 53% AD + vascular– 7% FTD + vascular

• Imaging most helpful:– When diagnosis is difficult due to atypical features– To test clinical impression– To clarify complex etiologies

Research and Clinical Trials

• CSF biomarkers as indicators of AD risk– Amyloid beta , Tau

• Novel PET imaging compounds– FDA approval of amyloid imaging agents

• Not currently approved for clinical diagnostic use

• Genetic testing• Preclinical diagnosis of AD

Clinical Trials

• Primary pathway to therapeutic progress• Depend on referrals from practicing

physicians and other providers• You can help!

– Check out Alzheimer’s Association Trial Match

http://www.alz.org/research/clinical_trials/find_clinical_trials_trialmatch.asp

Specialist Referrals• Neuropsychologist (psychometric testing)

– Very mild impairment in highly intelligent persons– Atypical cognitive impairment mixed with psychiatric symptoms– Medicolegal indications (e.g. medical disability determinations)

• Neurologist– Difficult differential diagnosis– Rare disease suspected, e.g. CJD, NPH

• Geriatric psychiatrist– Difficult neurobehavioral problems– Ongoing management of patient + family

• Geriatrician– Frailty, falls

• Social worker– Care planning, caregiver support and community resources

• Psychologist– Psychotherapy for family members

An Integrative Framework for Dementia Care

Patient and Family

Care Partner

Differential Diagnosis

and

Staging

Neuropsychiatric Symptom Assessment & Management

Medical Comorbidity, Safety and Risk Management

Caregiver Assessment, Counseling,

Services, and Planning © 2008 Soo Borson MD

Evaluating the Quality of Dementia Care:New Measures

• AMA PCPI with AAN, AGS, AMDA, APA/AAGP, Alz Assoc, others• 10 quality measures, grouped into key domains

– Dementia assessment: cognition, stage, everyday functional deficits

– Screening for depressive symptoms– Neuropsychiatric symptom assessment and

management– Counseling about safety (falls, medications) and

driving– Comprehensive advance care planning and end of life

counseling– Caregiver education and support